Meda Pharmaceuticals, the company's branded pharmaceutical division, offers leading branded prescription medications for allergy treatment--Dymista, Aerospan, Astepro
and Astelin--as well as a number of high-quality, branded generic drugs.
The Abbreviated New Drug Application included contributions from both firms, who will share certain costs and benefits of Astepro
6 December 2011 - Swedish pharma company Meda AB (STO:MEDA A) said today its allergic rhinitis nasal spray Astepro
(azelastine) had been granted a patent in the USA valid until 2028.
A handful of products have received new product approvals in Europe, such as Zyclara, Astepro
, Onsolis and Edluar.
M2 EQUITYBITES-January 24, 2012-Perrigo files ANDA with US FDA for generic version of Astepro
nasal spray; announces patent infringement lawsuit by Meda Pharmaceuticals(C)2012 M2 COMMUNICATIONS http://www.
This was a result of rising sales of Astepro
, Astelin's follow-up, and also of reduced wholesale inventories.
(once-daily azelastine; Meda Pharma): head-to-head trials lead to a successful switch
In the USA, Astelin sales in local currency went down 20%, mainly due to the launch of the new Astepro
sales are increasing slightly, which is important to the launch of Dymista, our most important new product, which is being introduced in the US in the fall and provides a basis for strong growth.
Yesterday, Meda said that its once-daily nasal spray Astepro
is a new nasal spray for the treatment of allergic rhinitis.
2 September 2009 - Swedish pharma company Meda AB (STO: MEDA A) said today that its once-daily nasal spray Astepro